Sign In
Buy GILD
$125.16
+0.110 (+0.0880%)
At Close: Jun 24, 2026
7 Rock-Solid Healthcare Dividend Stocks to Buy in January
09:10am, Saturday, 06'th Jan 2024
The Pharmaceutical segment offers human health pharmaceutical products in: Oncology, Hospital acute care Immunology Neuroscience Virology Cardiovascular and diabetes Vaccine products, such as preventi
Gilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know
07:33pm, Friday, 05'th Jan 2024
In the most recent trading session, Gilead Sciences (GILD) closed at $83.31, indicating a -1.38% shift from the previous trading day.
Gilead's Dividend Growth Potential Looks Phenomenal
10:57am, Thursday, 04'th Jan 2024
Gilead Sciences is recovering from reduced Veklury (remdesivir) revenue following the height of the COVID-19 pandemic. The company, however, is making progress in HIV product sales and oncology, the l
Nasdaq 100 Alert: 7 Undervalued Tech Stocks Ready to Rocket in 2024
08:07am, Wednesday, 03'rd Jan 2024
The Nasdaq 100 had a banner year. After a disastrous 2022 that saw the tech-laden index lose one-third of its value, it rebounded sharply in 2023 soaring 55% to hit a new all-time high.
Gilead Sciences to Present at Upcoming Investor Conference
04:05pm, Thursday, 21'st Dec 2023
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #Biotech--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conference: J.P. Morgan Healthcare
3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone'
11:23am, Thursday, 21'st Dec 2023
Investors in search of high-risk, high-reward investments can often find them among the top biotech stocks to buy. Identifying worthwhile opportunities can be easier said than done when investing in b
Gilead (GILD), Compugen Collaborate for Immunotherapy Program
12:01pm, Wednesday, 20'th Dec 2023
Gilead (GILD) enters into a license agreement with Compugen for its pre-clinical immunotherapy program.
Gilead Sciences and Compugen strike commercialization deal for immunotherapy program
11:31am, Wednesday, 20'th Dec 2023
Gilead Sciences, Inc. (NASDAQ:GILD) announced that it has entered into an agreement with Compugen Ltd (NASDAQ:CGEN) to exclusively license Compugen's pre-clinical antibody program against IL-18 bindi
Compugen stock rockets on anti-tumor drug deal with Gilead
07:13am, Tuesday, 19'th Dec 2023
Compugen Ltd.'s stock CGEN, -3.36% was up by 113% in premarket trading on Tuesday after the company said it agreed to sell exclusive rights to Gilead Sciences Inc. GILD, -1.03% for later stage develop
Gilead (GILD) Outperforms Industry in 6 Months: What Lies Ahead?
02:17pm, Friday, 15'th Dec 2023
Gilead (GILD) gains 3.7% in six months as its oncology portfolio gains traction and its HIV business maintains momentum.
Gilead Sciences (GILD) Stock Sinks As Market Gains: Here's Why
07:32pm, Thursday, 14'th Dec 2023
In the closing of the recent trading day, Gilead Sciences (GILD) stood at $81.78, denoting a -1.58% change from the preceding trading day.
A Bull Market Is Coming: 1 Stock That Could Rocket 219% Higher in 2024, According to Wall Street
05:29am, Tuesday, 12'th Dec 2023
Wall Street analysts following Iovance Biotherapeutics set price targets that suggest the stock can triple your money in 2024. Iovance Biotherapeutics is developing cell-based cancer therapies, and th
6 Health Care Dividend Stocks To By Hand Over Fist
10:48am, Monday, 11'th Dec 2023
This biotech giant remains a top stock for investors to buy and pays a solid 3.13% dividend.
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
01:48pm, Sunday, 10'th Dec 2023
Chimeric antigen receptor T-cell medicines could have more risks than previously known. Novartis' drug Kymriah is going to be under the most scrutiny for now.
Dividend Lovers Betting Big on 6 Goldman Sachs Top Conviction List Picks for 2024
09:12am, Saturday, 09'th Dec 2023
This integrated giant is safer for investors looking to get positioned in the energy sector, has backed up some, and now yields a strong 4.17% dividend.
